ReShape Lifesciences Unleashes AI-Powered Neurorehab Revolution with Motion Informatics Deal
DENVER, Colo., Apr 10, 2025 (247marketnews.com)- ReShape Lifesciences (NASDAQ:RSLS) just inked a deal with Motion Informatics to exclusively bring their next-gen neuromuscular rehabilitation tech to the U.S. Unveiled today, this partnership catapults ReShape into the estimated $10 billion neurorehab market with the Stimel-03, a game-changer showcased at the American Occupational Therapy Association (AOTA) 2025 Annual Conference and Expo in Philadelphia, April 3-5.
Paul F. Hickey, CEO and President of ReShape Lifesciences, stated, “The signing of this agreement with Motion Informatics marks a significant milestone for ReShape as we expand and diversify into rehabilitation technology. This partnership presents a unique opportunity to bring cutting-edge, neurorehabilitation solutions to the U.S. market. We are particularly excited to distribute the FDA cleared and commercially available Stimel-03, a breakthrough system that integrates Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), and real-time electromyographic (EMG) biofeedback into a single, patient-responsive platform—redefining rehabilitation for patients recovering from stroke, injury, or surgery. Motion Informatics’ innovative devices align well with our commitment to improving patient outcomes, complementing our core competencies including commercialization of differentiated products including our Lap-Band® 2.0 FLEX, designed to improve patients’ quality of life while driving meaningful clinical and commercial impact.”
The Stimel-03, FDA-cleared and ready to roll, fuses Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), and real-time EMG biofeedback into a patient-responsive powerhouse, redefining recovery for stroke, injury, and surgery survivors.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (RSLS)
- Afternoon Watchlist Builds as Busy Biotech, Blockbuster IPs & Big Institutional Bets Power Late-Day Surge
- MoBot’s Stock Market Highlights – 08/13/25 12:00 PM
- Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
- 24/7 Market News Snapshot 13 August, 2025 – ReShape Lifesciences, Inc. Common Stock (NASDAQ:RSLS)
- ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System